Your browser doesn't support javascript.
loading
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill, T J; Hogge, D E; Toze, C L; Nantel, S H; Power, M M; Abou Mourad, Y R; Song, K W; Lavoie, J C; Forrest, D L; Barnett, M J; Shepherd, J D; Nitta, J Y; Wong, S; Sutherland, H J; Smith, C A.
Affiliation
  • Nevill TJ; The Leukaemia Bone Marrow Transplantation Program of British Columbia, Division of Hematology, Vancouver General Hospital, Vancouver, British Columbia, Canada. tnevill@bccancer.bc.ca
Bone Marrow Transplant ; 42(10): 659-66, 2008 Nov.
Article in En | MEDLINE | ID: mdl-18679372
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Hematopoietic Stem Cell Transplantation / Myeloablative Agonists Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2008 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Neoplasms, Second Primary / Hematopoietic Stem Cell Transplantation / Myeloablative Agonists Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2008 Document type: Article Affiliation country: Country of publication: